We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Aida Libombo, Mozambique's deputy health minister, has announced that the government is working hard ensure that the number of HIV-positive people in the country receiving antiretroviral (ARV) drugs in the country increases from 25,000 to 55,000 by the end of this year.
The U.S. FDA has declined to review Canada-based Cardiome Pharma's new drug application (NDA) for an investigational cardiovascular drug, the company announced.
British drugmaker Allergan has received approval from the European Commission to market Ganfort, the company's Lumigan/timolol combination product (bimatoprost/timolol ophthalmic solution) for the treatment of glaucoma, in the EU.
Japan-based Astellas Pharma has announced that Vesicare (solifenacin succinate), indicated for the treatment of the overactive bladder (OAB), will be available in the Japanese market this month in 2.5 mg and 5 mg tablets.
Health Minister Tony Abbott has denied a claim by a pharmaceutical industry insider that he threatened drug companies against marketing abortion pill RU486.
Biogen Idec and Fumapharm AG, a privately held pharmaceutical company, today announced that they have signed a definitive agreement for the acquisition of Fumapharm by Biogen Idec.
Dr. Reddy's Laboratories, pharmaceutical producer, reported that Q4 loss narrowed to 236 million rupees ($5 million) against 520 million ($11 million) in the year-ago period on 64% higher revenue.
Dusa Pharmaceuticals and PhotoCure ASA today announced a licensing agreement under which Dusa grants PhotoCure a worldwide license under its patents relating to ALA esters.
Techedge, Inc. is pleased to announce that China BioPharma Limited, the Company's wholly owned subsidiary, has received final approval from the PRC's (Peoples Republic of China) State Regulatory Agency for the investment of China BioPharma, into Zhejiang Tianyuan Biotech Co., Ltd.